![美股開市前:股指期貨轉跌 美元指數觸及106 金價跌至2300美元附近](https://i-invdn-com.investing.com/news/moved_small-LYNXMPEJ5K0JR_L.jpg)
注冊以創建關於儀器的通知
你所追隨的作者的經濟活動和內容
免費註冊 已有帳戶? 登入
Vaccinex Inc是一家臨床階段的生物技術公司。該公司從事靶向生物療法的發現和開發,以治療未滿足醫療需求的疾病和病症,包括癌症、神經退行性疾病和自身免疫性疾病。該公司主要候選產品pepinemab(VX15/2503)是一種人源化單克隆抗體,可結合併阻斷SEMA4D的信號活性。該公司專注於開髮用於治療某些癌症適應症的pepinemab,特別是頭頸部鱗狀細胞癌 (HNSCC) 以及神經退行性疾病,包括亨廷頓病 (HD) 和阿爾茨海默病 (AD)。該公司使用其ActivMAb抗體發現平台發現了VX5。VX5是CXCL13的人類抗體,是一種調節免疫組織形成的分子,目前正處於臨床前開發階段,用於治療多發性硬化症 (MS) 和其他自身免疫性疾病。
名稱 | 年齡 | 成立於 | 主旨 |
---|---|---|---|
Maurice Zauderer | 75 | 2001 | Co-Founder, CEO, President & Director |
Albert D. Friedberg | 74 | 2001 | Chairman of the Board |
Bala S. Manian | 77 | 2004 | Independent Director |
Leisha A Emens | - | - | Scientific & Clinical Advisor |
Ramesh Ramanathan | - | - | Scientific & Clinical Advisor |
Max Vasquez | - | - | Member of Scientific & Clinical Advisory Board |
Amita Patnaik | - | - | Scientific & Clinical Advisor |
Laura J. Balcer | - | - | Scientific & Clinical Advisor |
Steven L. Galetta | - | - | Scientific & Clinical Advisor |
Charles Warren Olanow | - | - | Scientific & Clinical Advisor |
David M. Essayan | - | - | Scientific & Clinical Advisor |
Gerald E. Van Strydonck | 77 | 2003 | Independent Director |
Andrew Feigin | - | - | Scientific & Clinical Advisor |
Ray Dorsey | - | - | Scientific & Clinical Advisor |
Matilde Inglese | - | - | Scientific & Clinical Advisor |
Jacob B. Frieberg | 65 | 2015 | Independent Lead Director |
Susan Jerian | - | - | Scientific & Clinical Advisor |
Karl Kieburtz | - | - | Scientific Advisor |
Khurram Bashir | - | - | Scientific and Clinical Advisor |
Elizabeth M. Jaffe | - | - | Scientific & Clinical Advisor |
Mark J. Tullman | - | - | Scientific and Clinical Advisor |
Anthony W. Tolcher | - | - | Scientific and Clinical Advisor |
Jeffrey A. Cohen | - | - | Scientific & Clinical Advisor |
Peter A. Calabresi | - | - | Scientific & Clinical Advisor |
Andrew D. Goodman | - | - | Scientific & Clinical Advisor |
Barbara Yanni | 68 | 2015 | Independent Director |
Chrystyna Bedrij Stecyk | 59 | 2020 | Independent Director |
你確定要封鎖 %USER_NAME%?
此舉將會令你與 %USER_NAME% 之間無法看見對方的Investing.com貼文。
%USER_NAME% 已成功加入你的封鎖清單
你剛解除此人的封鎖,必須等候 48 小時後才可再次封鎖。
我覺得這個評論是:
謝謝!
您的報告已被發送到我們的版主審核